Biostatistics Sr Mgr
Amgen
Summary
In this vital role you will achieve results through detailed goal setting, accountability measures, effective partnership, performance management, collaboration with other groups and a dedication to serving customers, both inside and outside of Global Study Operations (GSO).
Job description
What you will do
In this vital role you will achieve results through detailed goal setting, accountability measures, effective partnership, performance management, collaboration with other groups and a dedication to serving customers, both inside and outside of Global Study Operations (GSO).
The Senior Biostatistics Manager independently leads sophisticated studies and projects in the oncology therapeutic area, ensuring that the statistical aspects of clinical activities meet required standards and are robust and valid. Will also influence and supply to strategy development, defend statistical approaches and represent GBS through participating in and collaborating with multidisciplinary project teams.
- Utilizing knowledge and expertise to inform and provide sound statistical guidance to areas and teams in clinical development, reimbursement, and medical affairs.
- Implementing, managing and supporting standards, technical quality and consistent approaches in strategy, study design and statistical analysis.
- Planning and executing statistical contributions to protocols, Flash Memos and Clinical Study Reports (CSRs).
- Providing input for clinical publications and regulatory filing documents.
- Leading all aspects of work performed by study statisticians.
- Performing statistical and exploratory analysis of studies/projects and developing conclusions and recommendations.
- Anticipating and communicating resource and quality challenges that could impact results or timelines.
- Solid understanding of regulatory guidelines in oncology drug development.
- Staying current in developments in the field of statistics in drug development (innovative trial design) and Amgen's statistical policies, procedures and strategies.
- Contributing to process improvements and operational efficiencies.
Basic Qualifications
Doctorate degree
Or Master's degree and 4 years of Biostatistics experience
Or Bachelor's degree and 6 years of Biostatistics experience
Preferred Qualifications
- Doctorate degree in biostatistics or statistics.
- 5 or more years of pharma/biotech statistical experience.
- Life cycle drug development experience (pre-clinical, clinical and post-marketing).
- Experience with oncology drug development.
- Proven in leadership and motivating multi-functional team to advance complex projects to completion and thoughtfully negotiate and influence
- Strong verbal and written communication combined with organizational skills and cross-cultural sensitivity
- Statistical leadership and contribution to regulatory and reimbursement submissions.
- Strong working knowledge of theoretical and applied statistics and of regulatory guidelines.
- Experience working effectively in a globally dispersed team environment with cross-cultural partners.
Requirements
- Doctorate degree, or Master's degree and 4 years of Biostatistics experience, or Bachelor's degree and 6 years of Biostatistics experience
- Solid understanding of regulatory guidelines in oncology drug development
- Strong working knowledge of theoretical and applied statistics
- Statistical leadership and contribution to regulatory and reimbursement submissions
- Leadership and ability to motivate multi-functional teams
- Strong verbal and written communication and organizational skills
- Cross-cultural sensitivity and global team collaboration
Benefits
- Health Insurance
- Dental Coverage
- Vision Coverage
- Life Insurance
- Disability Insurance
- Retirement and Savings Plan
- Flexible Spending Accounts
- Annual Bonus Program
- Stock-Based Long-Term Incentives
- Paid Time-Off
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.